You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

extragonadal germ cell tumor

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Th1, Th2, Th17 Phenotype in Urea Cycle Disorders

Active, not recruiting
  • Urea Cycle Disorder
  • Lysinuric Protein Intolerance
    • Istanbul, Turkey
      Istanbul University-Cerrahpasa
    Jan 23, 2023

    Esophageal Squamous Cell Carcinoma Trial in Chengdu (Toripalimab)

    Active, not recruiting
    • Esophageal Squamous Cell Carcinoma
    • Chengdu, Sichuan, China
      Sichuan Cancer Hospital and Research Institute
    Feb 8, 2022

    Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)

    Recruiting
    • Advanced Solid Tumors
    • +5 more
    • Scottsdale, Arizona
    • +7 more
    Jan 23, 2023

    Metastatic Malignant Tumor, Metastatic Malignant Tumor in the Brain Trial in Houston (Cognitive Assessment, Quality-of-Life

    Active, not recruiting
    • Metastatic Malignant Neoplasm
    • Metastatic Malignant Neoplasm in the Brain
    • Cognitive Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2021

    Prostate Cancer, Tumor, Residual Trial in New York (LUM Imaging System)

    Terminated
    • Prostate Cancer
    • Neoplasm, Residual
    • LUM Imaging System
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Feb 8, 2022

    Solid Tumor, NSCLC Metastatic Trial in Guanzhou (Ensartinib)

    Recruiting
    • Solid Tumor
    • Non-Small Cell Lung Cancer Metastatic
    • Guanzhou, Guangdong, China
      Sun yat-sen Univerisity Cancer Center
    Nov 22, 2021

    During MR-guided Radiation Therapy for Glioblastoma

    Recruiting
    • Glioblastoma Multiforme
    • Low field (0.35 T) MR-images of the brain at a MRIdian® linac system
    • Zürich, Zurich, Switzerland
      University Hospital Zurich
    Sep 29, 2022

    Advanced Malignant Solid Tumor Trial in France, Netherlands (MP0317, a tri-specific fibroblast activation protein (FAP) x CD40

    Recruiting
    • Advanced Malignant Solid Tumor
    • MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate
    • Lyon, Cedex 08, France
    • +3 more
    Nov 4, 2022

    Solid Tumor Trial in United States (Sirolimus, Cyclophosphamide, Etoposide)

    Recruiting
    • Solid Tumor
    • Atlanta, Georgia
    • +4 more
    Feb 8, 2022

    Prostate Cancer Trial in Belgium, Germany, Switzerland (radiation therapy)

    Active, not recruiting
    • Prostate Cancer
    • radiation therapy
    • Antwerpen, Belgium
    • +27 more
    Feb 24, 2022

    ICIs Plus Chemotherapy for Advanced ESCC.

    Active, not recruiting
    • Metastatic Esophageal Squamous Cell Carcinoma
    • Anti-PD-1 Immune Checkpoint Inhibitors
    • Bengbu, Anhui, China
    • +22 more
    Nov 21, 2021

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +2 more
    • SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 13, 2022

    Hydroxychloroquine, Gemcitabine, Lung Tumors Trial (Hydroxychloroquine Combined With Gemcitabine)

    Not yet recruiting
    • Hydroxychloroquine
    • +2 more
    • Hydroxychloroquine Combined With Gemcitabine
    • (no location specified)
    Dec 3, 2022

    Breast Tumor, Chemo Effect Trial in Hong Kong (Magnetic seed localization)

    Recruiting
    • Breast Neoplasm
    • Chemotherapy Effect
    • Magnetic seed localization
    • Hong Kong, Hong Kong
      University of Hong Kong
    Jun 16, 2022

    Breast Cancer Trial in United States (KIBUR MICRODEVICE, anthracycline and taxane based chemo)

    Active, not recruiting
    • Breast Cancer
    • KIBUR MICRODEVICE
    • anthracycline and taxane based chemotherapy
    • Basking Ridge, New Jersey
    • +5 more
    Jun 20, 2022

    Sickle Cell Disease Trial in Boston (WE CARE SDoH Screening Survey, Family Resource Book, Standard of care)

    Enrolling by invitation
    • Sickle Cell Disease
    • WE CARE SDoH Screening Survey
    • +2 more
    • Boston, Massachusetts
      Boston Medical Center
    Jan 18, 2022

    Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis Trial in São Paulo (Recombinant Herpes Zoster Vaccine (RZV),

    Recruiting
    • Rheumatoid Arthritis
    • +9 more
    • Recombinant Herpes Zoster Vaccine (RZV)
    • +5 more
    • São Paulo, Sao Paulo, Brazil
      Rheumatology Division of Hospital das Clínicas da Faculdade de M
    May 24, 2023

    Hiv, Vaccine Reaction, Microbial Colonization Trial (B. infantis Rosell®-33, Placebo)

    Not yet recruiting
    • Hiv
    • +3 more
    • B. infantis Rosell®-33
    • Placebo
    • (no location specified)
    Jun 19, 2023

    Breast Tumors Trial in Nottingham (Immunostimulating Interstitial Laser Thermotherapy)

    Terminated
    • Breast Neoplasms
    • Immunostimulating Interstitial Laser Thermotherapy
    • Nottingham, United Kingdom
      Nottingham Breast Cancer Institute
    Jul 2, 2021

    NSCLC, Metastatic Lung Non-Small Cell Carcinoma, Non Small Cell Lung Cancer Trial (Palliative Radiotherapy: 5 x 4Gy, chemo +

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • Palliative Radiotherapy: 5 x 4Gy
    • chemotherapy + immune checkpoint inhibitors
    • (no location specified)
    Jun 27, 2022

    Contraception Trial in Portland (DMPA, Etonogestrel implant)

    Not yet recruiting
    • Contraception
    • DMPA
    • Etonogestrel implant
    • Portland, Oregon
      OHSU
    Mar 13, 2023

    Nausea, Vomiting, Head and Neck Squamous Cell Carcinoma Trial in Beijing (Olanzapine)

    Recruiting
    • Nausea
    • +3 more
    • Beijing, Beijing, China
      Ye Zhang
    Jan 8, 2022

    Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,

    Active, not recruiting
    • Estrogen Receptor Negative
    • +3 more
    • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
    • +3 more
    • Houston, Texas
    • +5 more
    Feb 11, 2022

    HIV Trial in United States (Thalidomide)

    Completed
    • HIV Infections
    • Aurora, Colorado
    • +5 more
    Oct 27, 2021

    Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

    Recruiting
    • Hematologic Diseases
    • Allogeneic Stem Cell Transplant
    • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
    • Palo Alto, California
      Lucile Packard Children's Hospital
    Feb 2, 2022